Endocannabinoid System & Psychosis Risk: Clinical Evidence
Clinical evidence highlights the role of the endocannabinoid system psychosis risk in first episode psychosis. Identifying risk factors early can improve treatment outcomes. This research supports coordinated care to reduce legal system involvement.
A huge study finds a link between cannabis use in teens and psychosis later – WBAA
WHY IT MATTERS: If you are a parent, caregiver, or young adult patient, this research reinforces that cannabis therapies should be reserved for adults with clinical oversight, and that adolescent use without medical necessity carries real psychiatric…
Cannabis Use Associated with Worse Working Memory – EMJ
Heavy cannabis use working memory effects are linked to reduced brain activation during memory tasks. Dose, frequency, and cannabinoid profile influence cognitive outcomes. Medical patients using low-to-moderate doses face a different risk profile.
